Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial

NCT07721363 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Lupus Nephritis
Membranous Nephropathy

Interventions

DRUG: Obinutuzumab

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]